Skip to content

    Milestone Pharmaceuticals (MIST) stock price & financials

    View MIST earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance34.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    $0
    $238.0K
    $559.0K
    Operating Profit
    -$9.62M
    -$12.35M
    -$20.52M
    -$12.53M
    -$11.83M
    -23.0%
    -$17.26M
    -39.8%
    -$23.66M
    -15.3%
    -$25.63M
    -104.5%
    Weakening
    Net Profit
    -$9.44M
    -$12.36M
    -$20.76M
    -$12.97M
    -$11.92M
    -26.3%
    -$17.41M
    -40.8%
    -$26.07M
    -25.6%
    -$28.61M
    -120.7%
    Weakening
    EPS
    $-0.14
    $-0.31
    $-0.20
    $-0.12
    +14.3%
    $-0.20
    +35.5%
    $-0.21
    -5.0%
    Strengthening
    Other Income
    Interest
    $903.0K
    $919.0K
    $935.0K
    $951.0K
    $967.0K
    +7.1%
    $985.0K
    +7.2%
    $4.13M
    +342.2%
    $4.72M
    +396.8%
    Strengthening
    Depreciation
    Profit before Tax
    MarginsOPM
    -9942.4%
    -4585.0%
    Tax
    ReturnsROIC
    9.4%
    12.3%
    20.7%
    12.9%
    11.9%
    +26.3%
    17.4%
    +40.8%
    26.0%
    +25.6%
    28.5%
    +120.7%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$85.95M$119.82M$72.31M$114.14M$7.64M$13.76M$25.31M$73.05M$169.73M
    Short-Term Investments
    Total Current Assets$88.05M$122.50M$148.69M$118.92M$71.80M$73.03M$73.93M$111.92M$180.33M
    Net PP&E$351.0K$929.0K$1.29M$926.0K$2.68M$2.19M$1.57M$1.64M$1.30M
    Goodwill
    Intangibles
    Total Assets$88.08M$123.43M$149.97M$119.85M$74.48M$75.23M$75.50M$113.56M$181.63M
    LiabilitiesTotal Current Liabilities$4.53M$8.33M$6.16M$6.78M$6.14M$7.23M$8.13M$13.98M$22.18M
    Short-Term Debt
    Long-Term Debt$0$49.77M$53.35M$57.19M$59.21M
    Long-Term Leases$184.0K$696.0K$474.0K$2.00M$1.46M$874.0K$539.0K$192.0K
    Total Liabilities$4.53M$8.51M$6.86M$7.25M$8.13M$58.45M$62.35M$71.79M$163.41M
    EquityCommon Stock & APIC$2.04M$226.25M$251.68M$251.90M$273.90M$260.50M$288.05M$352.62M$384.99M
    Retained Earnings-$58.27M-$113.50M-$163.47M-$207.95M-$266.34M-$326.03M-$367.55M-$430.60M-$485.28M
    Total Equity$83.55M$114.92M$143.12M$112.60M$66.35M$16.77M$13.15M$41.77M$18.22M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$21.05M-$51.15M-$50.73M-$33.22M-$52.47M-$46.42M-$28.85M-$49.04M-$61.29M
    Cash from Investing$16.00M-$384.0K-$70.00M$70.00M-$57.12M$4.76M$8.28M$11.25M-$319.0K
    Cash from Financing$80.11M$85.41M$73.22M$5.05M$3.09M$47.79M$32.12M$85.53M$188.84M
    SummaryCapital Expenditure-$5.0K-$413.0K-$272.0K-$112.0K-$33.0K-$302.0K-$356.0K
    Free Cash Flow-$21.05M-$51.56M-$52.74M-$46.54M-$28.88M-$49.34M-$61.65M
    FCF Margin

    Ratios